Venous thromboembolism - dabigatran
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults
Summary
Dabigatran etexilate is recommended as a possible treatment to reduce the risk of venous thromboembolism in adults who have surgery to replace their hip or knee joint.
Guidance documents
Implementing this guidance
Other information
We will consult on our review plans for this guidance in June 2011
About this guidance
Technology appraisals TA157
Issued: September 2008
How this guidance was produced